SCHEMBL15426458

SCHEMBL15426458

CCSc1ccccc1-c1nc2cc(C)cc(N)c2n1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ ATM Q13315 1/20 0.34
▸ SLC6A4 P31645 4/20 0.34
▸ SLC6A3 Q01959 4/20 0.34
▸ SLC6A2 P23975 3/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ DHODH Q02127 1/20 0.34
▸ ATR Q13535 1/20 0.34
▸ MAPT P10636 3/20 0.33
▸ LMNA P02545 3/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ NR1I2 O75469 1/20 0.33
▸ HSD11B1 P28845 1/20 0.33
▸ ALOX5AP P20292 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15426350 0.85 NPC1 (0.34) NPC1ATMDHODHMAPTNR1I2
SCHEMBL15426346 0.85 HSD11B1 (0.39) NPC1SMN1; SMN2RAB9ACYP1A2ATM
SCHEMBL9953119 0.85 SLC6A2 (0.38) NPC1SMN1; SMN2RAB9ACYP1A2CYP3A4
SCHEMBL15426338 0.79 NLRP3 (0.46) NPC1SMN1; SMN2RAB9ACYP1A2ATM
SCHEMBL15412355 0.77 AKT1 (0.39) NPC1CYP1A2ATMATRLMNA
SCHEMBL10280700 0.75 BRD4 (0.40) NPC1SMN1; SMN2RAB9ACYP1A2CYP3A4
SCHEMBL9958612 0.74 HSD11B1 (0.38) NR1I2HSD11B1
SCHEMBL20708646 0.74 DDR1 (0.34) NPC1ATMSLC6A4SLC6A3SLC6A2
SCHEMBL9958588 0.74 HSD11B1 (0.34) NPC1SMN1; SMN2ATMALDH1A1HSD11B1
SCHEMBL16280478 0.72 NPC1 (0.36) NPC1SMN1; SMN2RAB9AATMATR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278983-B2 Fused heterocyclic compound and use thereof for pest control SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-03-08 — — US disclosed
US-20140364444-A1 FUSED HETEROCYCLIC COMPOUND AND USE THEREOF FOR PEST CONTROL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-12-11 — — US disclosed
US-8853238-B2 Fused heterocyclic compound and use thereof for pest control SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-10-07 — — US disclosed
US-20140018373-A1 FUSED HETEROCYCLIC COMPOUND AND USE FOR PEST CONTROL THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-01-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140018373-A1 FUSED HETEROCYCLIC COMPOUND AND USE FOR PEST CONTROL THEREOF NR4A1, NR2C2, NR0B1 NPC1 2008/4885SMN1; SMN2 2358/4885RAB9A 694/4885
US-20140364444-A1 FUSED HETEROCYCLIC COMPOUND AND USE THEREOF FOR PEST CONTROL NR4A1, NR2C2, NR0B1 NPC1 2099/4885SMN1; SMN2 2445/4885RAB9A 697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback